| Pharmaceuticals Industry | Healthcare Sector | Dr. Severin Schwan Ph.D. CEO | LSE Exchange | CH0012032048 ISIN |
| US Country | 103,605 Employees | 27 Mar 2025 Last Dividend | 4 May 2001 Last Split | - IPO Date |
Roche Holding AG is a global leader in healthcare, with a strong focus on pharmaceuticals and diagnostics. The company has a presence across Europe, North America, Latin America, Asia, Africa, Australia, and Oceania, showcasing a truly international footprint. Founded in 1896, Roche has a long-standing history of innovation and dedication to improving health outcomes. Based in Basel, Switzerland, this esteemed company has been at the forefront of developing and providing solutions to some of the most pressing health challenges faced around the world.
Roche Holding AG offers a broad portfolio of products and services, catering to a wide range of therapeutic areas and diagnostic needs:
These include a variety of medications aimed at treating conditions in therapeutic areas such as anemia, various types of blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune diseases, neurological disorders, ophthalmology, respiratory disorders, and transplantation. Roche is also actively developing new pharmaceutical products to address unmet medical needs in these and other areas.
Roche provides a comprehensive range of diagnostic tests for the detection of diseases like cancer, diabetes, Covid-19, hepatitis, human papillomavirus (HPV), among others. These diagnostic tools are essential in the early detection, diagnosis, and monitoring of diseases, leading to better patient outcomes.
The company also offers advanced diagnostic instruments used by laboratories, hospitals, and healthcare providers globally. These instruments are crucial for conducting the in vitro diagnostic tests, ensuring accuracy and efficiency in diagnostics.
Understanding the increasing role of technology in healthcare, Roche is also involved in offering digital health solutions. These innovative technologies aim to improve patient care, enhance diagnostic and therapeutic processes, and enable healthcare providers to deliver more personalized and efficient care.